Analyst Richard Purkiss is focused on the Healthcare sector with 36 price targets and ratings documented since 2015 spanning on 3 stocks. Previously, Richard Purkiss worked at PIPER SANDLER. Analyst's average stock valuation to be materialised ratio is 100% with an average time for price targets to be met of 1359.67 days.
Most recent stock forecast was given on PFE, Pfizer Inc at 08-Jan-2018.
Richard Purkiss best performing recommendations are on LLY (ELI LILLY AND COMPANY).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 10/24/2017. The price target of $107 was fulfilled within 349 days with a profit of $30.06 (39.07%) receiving and performance score of 1.12.
Average potential price target upside
Currently, out of the existing stock ratings of Richard Purkiss - 2194 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
48
$8.01 (20.03%)
49
1 months 28 days ago
27/29 (93.1%)
$7.01 (26.65%)
623
1.04
Buy
75
$35.01 (87.55%)
75
1 months 28 days ago
9/13 (69.23%)
$17.92 (49.80%)
850
0.5
Hold
45
$5.01 (12.53%)
53
1 months 28 days ago
10/11 (90.91%)
$4.85 (18.46%)
402
2.3
Hold
44
$4.01 (10.03%)
49
1 months 28 days ago
11/11 (100%)
$2.33 (6.28%)
73
4
